Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) vs Uruguay: Immunization, measles
Immunization, measles over time
- Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)
- Uruguay
How they compare
Uruguay currently reports 97.0% against 83.6% in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD), a difference of 13.4%.
That makes Uruguay's figure about 1.2 times Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD)'s.
Across all 45 years both countries report, Uruguay has been ahead every year.
Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 29th and Uruguay ranks 31st of 47 groups.
Uruguay has averaged higher in every one of the 5 decades both report.
Head to head by decade
| Decade | Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) | Uruguay | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 40.3% | 67.1% | 26.8% | Uruguay |
| 1990s | 69.5% | 93.2% | 23.7% | Uruguay |
| 2000s | 73.7% | 94.2% | 20.5% | Uruguay |
| 2010s | 79.3% | 95.8% | 16.5% | Uruguay |
| 2020s | 82.2% | 95.4% | 13.2% | Uruguay |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, measles, Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) or Uruguay?
- Uruguay, at 97.0% against 83.6% in Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) as of 2024.
- What is the difference in immunization, measles between Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) and Uruguay?
- 13.4%, with Uruguay ahead.
- How many years of comparable data are there for Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) and Uruguay?
- 45 years are reported by both, from 1980 to 2024.
- How do Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) and Uruguay rank globally for immunization, measles?
- Middle East, North Africa, Afghanistan & Pakistan (IDA & IBRD) ranks 29th and Uruguay ranks 31st of 47 groups.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, measles (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.